Literature DB >> 8730834

Ultrasonic vocalization (22-28 kHz) in a model of chronic pain, the arthritic rat: effects of analgesic drugs.

B Calvino1, J M Besson, A Boehrer, A Depaulis.   

Abstract

Adjuvant-induced arthritis in rats is considered as a chronic pain model. In a search for a relevant behavioural marker of the chronic pain state, we studied social interactions between an arthritic rat and a healthy partner in a neutral cage. During the test, arthritic rats emitted ultrasonic 22-28 kHz vocalizations (USV), whereas control rats did not, and showed less exploration and more immobility, but did not differ from controls in terms of social behaviours (social investigation, allogrooming). Aspirin (200 mg kg < > (en)1) or morphine (3 mg kg < > (en)1) injected intraperitoneally before the test significantly decreased USV without affecting the animals' behaviour. These results suggest that USV could be associated with affect related to aversive or painful stimuli and may constitute a behavioural marker of chronic pain in arthritic rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730834     DOI: 10.1097/00001756-199601310-00049

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

Review 1.  Behavioral assessments of the aversive quality of pain in animals.

Authors:  Xu-Jie Zhang; Tian-Wei Zhang; San-Jue Hu; Hui Xu
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

2.  Validity of acute and chronic tactile sensory testing after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Leslie M Clark; Karen J Hutchinson; Anne D Kloos; Lesley C Fisher; D Michele Basso
Journal:  Exp Neurol       Date:  2010-07-17       Impact factor: 5.330

3.  Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.

Authors:  Gabriel S Bassi; Ana C Broiz; Margarete Z Gomes; Marcus L Brandão
Journal:  Psychopharmacology (Berl)       Date:  2008-12-18       Impact factor: 4.530

4.  Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors.

Authors:  Enza Palazzo; Yu Fu; Guangchen Ji; Sabatino Maione; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

5.  Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context.

Authors:  Jennifer M Wright; Jim C Gourdon; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2010-05-06       Impact factor: 4.530

6.  [The AMDS system for the documentation of symptoms and signs associated with pain].

Authors:  Teja W Grömer; Wolfgang Käfferlein; Björn Menger; Ralf Dohrenbusch; Bernd Kappis; Christian Maihöfner; Johannes Kornhuber; Alexandra Philipsen; Helge H O Müller
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

7.  Female- and Intruder-induced Ultrasonic Vocalizations in C57BL/6J Mice as Proxy Indicators for Animal Wellbeing.

Authors:  Brian J Smith; Kate E P Bruner; Lon V Kendall
Journal:  Comp Med       Date:  2019-10-02       Impact factor: 0.982

8.  Female Urine-induced Ultrasonic Vocalizations in Male C57BL/6J Mice as a Proxy Indicator for Postoperative Pain.

Authors:  Brian J Smith; Kate E P Bruner; Ann M Hess; Lon V Kendall
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-01-09       Impact factor: 1.232

9.  Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice.

Authors:  Jeffrey S Mogil; Allyson C Graham; Jennifer Ritchie; Sara F Hughes; Jean-Sebastien Austin; Ara Schorscher-Petcu; Dale J Langford; Gary J Bennett
Journal:  Mol Pain       Date:  2010-06-08       Impact factor: 3.395

10.  Differences in ultrasonic vocalizations between wild and laboratory California mice (Peromyscus californicus).

Authors:  Matina C Kalcounis-Rueppell; Radmila Petric; Jessica R Briggs; Catherine Carney; Matthew M Marshall; John T Willse; Olav Rueppell; David O Ribble; Janet P Crossland
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.